乌司他丁治疗急性肺损伤的临床疗效研究
2018-05-12杜国强欧少佳王华洪梁剑毅张森丁延龄
杜国强 欧少佳 王华洪 梁剑毅 张森 丁延龄
【摘要】 目的 探讨乌司他丁治疗急性肺损伤的临床疗效。方法 80例急性肺损伤患者, 随机分为对照组和实验组, 各40例。对照组患者采用常规治疗, 实验组患者在对照组基础上联合乌司他丁治疗, 观察比较两组患者治疗效果、呼吸频率(RR)、动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、氧合指数(PaO2/FiO2)、C反应蛋白(CRP)和乳酸水平差异。结果 实验组患者总有效率为90.00%, 明显高于对照组的70.00%, 差异有统计学意义(P<0.05)。实验组患者RR为(23.46±1.56)次/min, PaO2为(92.62±6.38)mm Hg(1 mm Hg=0.133 kPa), PaCO2为(33.99±4.95)mm Hg, PaO2/FiO2为(281.42±21.83)mm Hg,优于对照组的(27.86±1.74)次/min、(81.05±7.14)mm Hg、(38.85±5.29)mm Hg、(219.74±18.82)mm Hg, 差异有统计学意义(P<0.05)。实验组患者CRP为(30.24±3.81)mg/L, 乳酸为(1.01±0.15)mmol/L, 低于对照组的(41.75±3.53)mg/L、(1.52±0.37)mmol/L, 差异有统计学意义(P<0.05)。结论 针对急性肺损伤患者应用乌司他丁治疗可明显提高治疗效果, 改善血气指标和炎性指标, 促进患者康复, 值得推广应用。
【关键词】 乌司他丁;急性肺损伤;疗效
DOI:10.14163/j.cnki.11-5547/r.2018.13.002
【Abstract】 Objective To discuss the clinical efficacy of ulinastatin in the treatment of acute lung injury. Methods A total of 80 acute lung injury patients were randomly divided into control group and experimental group, with 40 cases in each group. The control group received conventional therapy, and the experimental group received ulinastatin on the basis of the conventional group. Observation and comparison were made on differences in treatment effect, respiratory rate (RR), partial pressure of oxygen (PaO2) partial pressure of carbon dioxide (PaCO2), oxygenation index (PaO2 /FiO2), C reactive protein (CRP) and lactic acid level between the two groups. Results The experimental group had obviously higher total effective rate as 90.00% than 70.00% in the control group, and the difference was statistically significant (P<0.05). The experimental group had RR as (23.46±1.56) times/min, PaO2 as (92.62±6.38) mm Hg (1mm Hg=0.133 kPa), PaCO2 as (33.99±4.95) mm Hg andPaO2 / FiO2 as (281.42±21.83) mm Hg, which were all better than (27.86±1.74) times/min, (81.05±7.14) mm Hg,(38.85±5.29) mm Hg and(219.74±18.82) mm Hg in the control group, and their difference was statistically significant (P<0.05). The experimental group had lower CRP as (30.24±3.81) mg/L, lactate as (1.01±0.15) mmol/Lthan (41.75±3.53)mg/L and (1.52±0.37) mmol/L in the control group, and their difference was statistically significant (P<0.05). Conclusion Application of ulinastatin in treating acute lung injury patients can obviously improve treatment effect, improve blood gas index and inflammatory index, and promote rehabilitation of patients. It is worthy of promotion and application.
【Key words】 Ulinastatin; Acute lung injury; Efficacy
急性肺損伤为临床常见呼吸系统急症, 若治疗不及时可引起急性呼吸窘迫综合征, 影响患者生活质量。如何提高急性肺损伤救治成功率, 避免病情发展, 为临床关注的焦点。乌司他丁为光谱水解酶抑制糖蛋白, 具有调节炎性细胞、炎性介质水平和氧自由基水平作用, 可保护肺功能[1]。本文通过对本院收治的80例急性肺损伤患者进行分组, 讨论临床治疗方案, 现报告如下。